O-CAL F.A. Rx
Generic Name and Formulations:
Vit. A 5000 IU, Vit C. 90mg, Vit. D 400 IU, Vit. E 30 IU, thiamine 3mg, riboflavin 3mg, niacin 20mg, pyridoxine 4mg, folic acid 1mg, Vit. B12 12mcg, calcium (as carbonate) 200mg, iron (as fumarate) 66mg, iodine (as potassium) 150mcg, magnesium (as oxide) 100mg, zinc (as oxide) 15mg, copper (as sulfate) 2mg, sodium fluoride 1.1mg; tabs; sugar- and dye-free.
Indications for O-CAL F.A.:
Nutritional supplement, prevention of dental caries where water fluoridation <0.6ppm.
1 tablet daily.
Water fluoridation >0.6ppm.
Dental fluorosis, eczema, atopic dermatitis, urticaria possible with excessive fluoride intake. Account for other sources of fluoride. Folic acid may mask pernicious anemia.
Insoluble calcium fluoride with dairy products.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|